topotecan has been researched along with Leukemia L 1210 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boehm, JC; Caranfa, MJ; Faucette, LF; Gallagher, G; Hecht, SM; Holden, KG; Jakas, DR; Johnson, RK; Kingsbury, WD; McCabe, FL | 1 |
| Besterman, JM; Leitner, P; Manikumar, G; Moore, L; Nicholas, AW; Tele, C; Truesdale, A; Wall, ME; Wani, MC | 1 |
| Cui, J; Li, C; Li, Y; Wang, C; Wei, N; Xiu, X; Zhang, L | 1 |
| Cui, J; Li, C; Wang, C; Wei, N; Yang, H; Zhao, X | 1 |
| Ganapathi, R; Grabowski, D | 1 |
| Aalders, M; El-Gawly, H; Gabr, A; Kuin, A; Smets, LA | 1 |
| Bally, M; Choice, E; Madden, TD; Masin, D; Redelmeier, T; Tardi, P | 1 |
7 other study(ies) available for topotecan and Leukemia L 1210
| Article | Year |
|---|---|
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity.
Topics: Animals; Antineoplastic Agents; Camptothecin; Cattle; Cell Line; Colonic Neoplasms; DNA, Superhelical; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Leukemia L1210; Lung Neoplasms; Melanoma, Experimental; Mice; Molecular Structure; Plasmids; Structure-Activity Relationship; Thymus Gland; Topoisomerase I Inhibitors; Transplantation, Heterologous | 1991 |
Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs.
Topics: Animals; Antineoplastic Agents; Camptothecin; Female; Humans; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred DBA; Molecular Conformation; Molecular Structure; Plants, Medicinal; Stereoisomerism; Structure-Activity Relationship; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1993 |
Nigericin-mediated liposome loading of topotecan: is nigericin a potential drug release regulator?
Topics: Animals; Cell Line, Tumor; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Carriers; Drug Compounding; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Nigericin; Survival Analysis; Time Factors; Topoisomerase I Inhibitors; Topotecan; Unilamellar Liposomes | 2010 |
Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Topics: Ammonium Sulfate; Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Carcinoma, Lewis Lung; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Half-Life; Hand-Foot Syndrome; Humans; Injections, Intravenous; Leukemia L1210; Liposomes; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasms; Phosphatidylethanolamines; Polyethylene Glycols; Prostatic Neoplasms; Random Allocation; Rats; Rats, Wistar; Skin; Skin Diseases; Tissue Distribution; Topoisomerase I Inhibitors; Topotecan | 2012 |
Cytotoxic efficacy with combinations of topoisomerase I and topoisomerase II inhibitors in sensitive and multidrug-resistant L1210 mouse leukemia cells.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Resistance, Multiple; Drug Synergism; Enzyme Inhibitors; Etoposide; Leukemia L1210; Mice; Mitoxantrone; Topoisomerase I Inhibitors; Topotecan | 1996 |
Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH.
Topics: Animals; Antineoplastic Agents; Camptothecin; DNA, Neoplasm; Hydrogen-Ion Concentration; Leukemia L1210; Mice; Mice, Inbred C3H; Topotecan | 1997 |
Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Drug Carriers; Female; Humans; Leukemia L1210; Liposomes; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Mice, SCID; Survival Rate; Topotecan; Transplantation, Heterologous | 2000 |